Covid-19
Germany approves clinical trial of coronavirus immunity vaccines
Germany has approved clinical trials of multiple vaccines developed by German biotech company, BioNTech, for treatment of coronavirus. Scientists were said to be monitoring the effectiveness of the vaccines in generating immunity against coronavirus. The clinical trial will be starting with 200 participants of 18 to 55 years age bracket.
Statistics from Johns Hopkins University shows that coronavirus has killed over 177,000 people and infected 2.5 million across the world. This was identified to have given impetus to the race to develop vaccines that can contain the spread of coronavirus and the associated deaths across the world.
About 86 teams were identified to be engaged on research and study for coronavirus vaccines across the world.
-
Football2 days agoArgentine presenter Florencia Peña resigns after false on-air report about Lionel Messi’s father
-
Business4 days agoNigeria launches FreeTV digital platform with over 100 free channels
-
Business2 days agoAward-winning Mitsubishi L200 gets anniversary price cut in Nigerian market
-
Latest6 days agoBREAKING: Court orders INEC to deregister ADC, Accord Party, others ahead of 2027 elections
-
News6 days agoObisesan empowers students, farmers others in Efon, receives praises from beneficiaries
-
Latest1 week agoPolitical tension in Osun as Adeleke accuses APC over attack on Osogbo monarch
-
Comments and Issues5 days agoA tale of two kidnappings
-
Football1 week agoQatar Stun Switzerland with Dramatic Late Equaliser